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Introduction: Obesity is a strong independent risk factor of gastroesophageal reﬂux disease (GERD)
symptoms and esophageal erosions. However the relationship between obesity and GERD is still a
subject of debate. In fact, if in most cases bariatric surgery can diminish reﬂux by losing a large amount of
fat, on the other hand some restrictive procedure can worsen or cause the presence of GERD. Thus, it is
unclear if patients candidate to bariatric surgery have to perform pre-operative reﬂux testing or not.
Aim: of the study was to verify the presence of GERD patterns in patients candidate to surgery and the
need of pre-operative reﬂux testing.
Methods: All patients underwent to a standardized questionnaire for symptoms severity (GERQ), upper
endoscopy, high resolution manometry (HRiM) and impedance pH-monitoring (MII-pH). Patients were
stratiﬁed into: group 1 (negative for both GERQ and endoscopy), group 2 (positive for GERQ and negative
for endoscopy), group 3 (positive for both GERQ and endoscopy). A healthy-volunteers group (HV) was
assessed.
Results: One hundred thirty-nine subjects (obese, 124; HV normal weight, 15) were studied. Group 1
showed comparable mean LES pressure, peristaltic function, bolus transport and presence of hiatal
hernia than HV. Group 2 showed a reduction of these parameters, while group 3 showed a statistical
signiﬁcant reduction in LES pressure, peristaltic function, bolus transport and increase in presence of
hiatal hernia.
At MII-pH, Group 1 showed a not signiﬁcant increase in reﬂux patterns; group 2 and 3 showed a sig-
niﬁcant increase in esophageal acid exposure and in number of reﬂuxes (both acid and weakly acid), with
group 3 showing the higher grade of reﬂux pattern.
Conclusions: Obese subjects with pre-operative presence of GERD symptoms and endoscopical signs
could be tested with HRM and MII-pH before undergoing bariatric surgery, especially for restrictive
procedures. On the other hand, obese patients without any sign of GERD could not be tested for reﬂux,
showing similar patterns to HV.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
The prevalence of gastroesophageal reﬂux disease (GERD) in
adults has continued to increase and currently ranges from 20 to
44% [1,2]. In particular, this escalation is thought to be linked to the
global rise in obesity [3e7]. This trend is of concern also because ofne).
by Elsevier Ltd. All rights reservedthe prevalence of esophagitis and Barrett’s esophagus ranges from
11.8 to 15.5% and from 1.3 to 1.6%, respectively [2,8], thus increasing
the risk of developing esophageal adenocarcinoma [9].
Obesity is considered as a risk factor for severe symptomatic
GERD often complicated with either ulcerated esophagitis and/or
Barrett’s esophagus [10,11].
There is a strong, positive association between obesity and
GERD in clinical studies. Obese patients have increased numbers of
reﬂux events and oesophageal acid exposure on pH studies [12,14]
and an increased risk of erosive esophagitis on endoscopy [15e19]..
S. Tolone et al. / International Journal of Surgery 12 (2014) S173eS177S174However, the association between obesity and reﬂux is some-
what controversial, as shown by a recent meta-analysis by Corley
and Kubo [20].
Such as morbid obesity, deﬁned as a body mass index (BMI)
≥30 kg/m2, has risen to epidemic proportions in several Western
countries, so too the use of bariatric surgery spread among
surgeons.
This kind of surgery is not only capable to obtain a rapid and
stable weight loss, but it can often relief obesity-related pathol-
ogies. However, these procedures can inﬂuence gastroesophageal
reﬂux in various ways, lowering or increasing it. Thus, it is uncer-
tain if a morbid obese patient must always be tested for reﬂux.
The aim of the current study was to verify the relationship be-
tween obesity and presence of GERD, and the consequent need to
test or not for reﬂux morbid obese patients candidate to bariatric
surgery.
2. Methods
2.1. Patients
One hundred forty-four consecutive obese patients candidate to
bariatric surgery (BMI > 35) were studied prospectively using a
standardized esophageal reﬂux testing protocol, including clinical
evaluation, upper endoscopy, high-resolution impedance manom-
etry and combined multichannel intraluminal impedance pH-
metry (MII-pH).
Twenty subjects had previous gastric surgery, or huge hiatal
hernia and were excluded.
Reﬂux testing data from the remaining 124 patients (72 men,
ages18e58) were analyzed. Patients were enrolled from the
Esophageal diagnostic laboratory at Second University of Naples
without regard to presenting complaint. Data from 25 healthy
volunteers (HV group, BMI 20e25, negative endoscopy, normal
HRiM and MII-pH) stored in our database were used as controls.
The local Institutional Review Board approved the study protocol,
and informed consent was obtained from each subject.
2.2. Clinical evaluation
Anthropometric measures were obtained on all patients
(weight, height, body mass index BMI).
The subjects were investigated about presenting symptoms
using a questionnaire incorporating a visual analog scale (0e10) for
heartburn, regurgitation, dysphagia, and chestpain [21]. Subjects
with predominant complaints of heartburn and/or regurgitation
were classiﬁed as probably having GERD (Symptomþ), whereas
subjects with predominant complaints of no heartburn and/or
regurgitation were classiﬁed as Symptoms.
2.3. Upper endoscopy
Endoscopy was performed according to International guide-
lines. Presence of esophagitis was graded according to Los Angeles
classiﬁcation [22], whereas the aspect of the gastro-esophageal ﬂap
valve was graded according to Hill classiﬁcation [23]. Subjects with
esophagitis and/or abnormalities of ﬂap valve were classiﬁed as
upper endoscopy probably positive for GERD (UEþ).
2.4. High-resolution manometry
Each patient underwent manometrical esophageal function
testing using HRiM with a 32- channel probe (Sandhill-HRiM
catheter InSight; Sandhill Scientiﬁc Inc., Highlands Ranch, CO, USA).
Data acquisition, display and analysis were performed usingdedicated software (Sandhill Bioview, Sandhill Sci.), after a proper
thermal compensation.
The patients underwent transnasal placement of the mano-
metric assembly and the catheter was positioned to record from the
hypopharynx to the stomach. Studies were done in a supine posi-
tion and the manometric assembly was positioned with at least 5
intragastric sensors to optimize EGJ and intragastric recording. The
catheter was then taped to the nose. The manometric protocol
included at least ten 5-mL swallows and a 5-min period to assess
basal sphincter pressure [24].
The lower esophageal sphincter (LES) was localized and its
pressure and relaxations evaluated; proximal and distal borders
were marked according to pressure difference related to intra-
esophageal and intragastric pressure marks. Crural diaphragm (CD)
was marked as the axial level characterized by maximal inspiratory
pressure augmentation.
In individuals with normal anatomy, LES and CD were super-
imposed and indistinguishable. Patients were then classiﬁed to
have normal EGJ or hiatal hernia, based on the presence of axial
separation between LES and CD, measured in cm. The gastro-
esophageal pressure gradient (GEPG) was calculated using the
average values of the simultaneous intraesophageal and intra-
gastric pressure measurements.
Regarding esophageal body contraction, patients were classiﬁed
to have normal or ineffective motility as well as described in
Literature [25]; in brief HRiM motility patterns were graded as the
recently developed Chicago Classiﬁcation [26] by means of esoph-
ageal pressure topography. Ineffective (or weak) peristalsis was
deﬁned as breaks of 2e5 cm in length in >30% of liquid swallows
(small defect) or breaks >5 cm in length in >20% of liquid swallows
(large defect) in the 20 mmHg isobaric contour plot. For each liquid
swallow, complete bolus transit occurred when the bolus entered
the ﬁrst pair of impedance sensors and exited the second, third and
fourth pair of sensors. The study was considered abnormal if
complete bolus transit occurred <80% of liquid swallows. Bolus
transit time (BTT) was expressed as time in seconds from entrance
of the bolus in the proximal channel to the exit in the most distal
impedance channel.
2.5. 24 h MII-pH
All patients underwent to outpatient 24 h MII-pH. Patients had
to observe fasting since the night before and had to be off medi-
cation (any kind of PPI or drugs affecting the normal gastroin-
testinal motility) at least for 5 days. A dedicated MII-pH catheter
(with intraluminal impedance segments positioned at 3, 5, 7, 9, 15
and 17 cm above the LES) (Sandhill Scientiﬁc Inc., Highlands
Ranch, CO, USA) was placed transnasally, with the esophageal pH
sensor positioned 5 cm above the manometrical determined LES.
Patients were invited to indicate 3 or more predominant symp-
toms that occur along the recording time, every meal and
changing position in upright or in recumbent, both on the device
and on a written diary provided as well. The catheter transmitted
information into software included in the device (Sleuth System e
Sandhill Scientiﬁc Inc., Highlands Ranch, CO, USA). MII-pH data
were collected and analyzed with the Bioview GERD Analysis
Software (Sandhill Scientiﬁc Inc., Highlands Ranch, Colorado,
USA). By means of MII-pH, the following variables were assessed:
distal esophageal acid exposure as percentage (%) of time with
pH < 4 (abnormal if total time with pH < 4 was greater than 6.3%,
and/or upright time with pH < 4 was greater than 4.2%, and/or
recumbent time with pH < 4 was greater than 1.2%), number and
quality (acid and weakly-acid) of reﬂux detected at MII (normal
value <73), and Symptom Association Probability (SAP), as
described in Literature [27e29].
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Parametric variables were summarized as mean and SD and
compared using ANOVA.
Nonparametric variables were summarized as median with
interquartile range (IQR) and compared using Wilcoxon nonpara-
metric tests (KruskalleWallis). A p < 0.05 was considered
signiﬁcant.3. Results
A total of 124 patients were studied (72men, 58% and 52 female,
42%). The mean age of the patients was 36.0 years (SD, 14.8) and
their mean height and weight were 167.3 cm (SD, 9.2) and 132.1 kg
(SD, 26.8), respectively. Mean BMI of the patients was 44.2 kg/m2
(SD, 7.0). Therewere no signiﬁcant differences in BMI betweenmen
and women.
Using visual analog scale data from the symptom assessment
questionnaire to assess severity of heartburn, regurgitation,
dysphagia, chestpain, and other miscellaneous symptoms, 102
subjects were classiﬁed as Symptomþ, whereas 22 resulted
Symptom. Symptomþ patients had signiﬁcantly increased mean
GERD severity scores (heartburn score and regurgitation score)
compared to subjects classiﬁed as Symptom (GERD 8.6, SD 3.5;
non-GERD 1.1, SD 2.9, P < 0.0001).3.1. Upper endoscopy
In 65 patients we recorded abnormalities of EGJ according to Hill
classiﬁcation. In particular, 23 subjects showed presence of hiatal
hernia (Hill grade 4), whereas the remaining 42 patients had a Hill
grade 2e3 (cardial incontinence). Only eighteen patients were
found to have esophagitis (10 grade A and 8 grade B, respectively).
According to the clinical and endoscopical ﬁndings, we stratiﬁed
obese patients into three groups as follows: group 1 (22 pts, 17.8%)
negative for symptoms and endoscopy, group 2 (37 pts, 29.8%)
positive for symptoms but negative for endoscopy, and group 3 (65
pts, 52.4%) positive for both.3.2. High-resolution manometry
Intragastric pressure was signiﬁcantly higher in obese patients
compared with HV group during both expiration and inspiration
(p < 0.001). There was no difference between group 1, 2 and 3,
respectively, regarding intragastric pressure values. Similar ﬁnd-
ings were noted about intraesophageal pressure, that was signiﬁ-
cantly higher in obese than HV, without any differences in the three
groups.
The mean GEPG during both inspiration and expiration was
signiﬁcantly increased in obese patients compared to normal
subjects.
Spatial separation between the LES and the CD increased in
obese patients compared to HV; however only in group 3 the spatialTable 1
Patterns of esophageal motility at HRiM. (P < 0.05 vs HV).
HV (n ¼ 15) Group
LES pressure (mmHg)
median (25the75th)
22.7 (15.8e40.2) 23.5 (1
Ineffective motility (%) 10 15
Complete bolus transit (%)
median (25the75th)
88 (82e95) 80 (70
Hiatal Hernia (%) 0 5separation was signiﬁcantly increase (hiatal hernia presence in 65/
65 pts).
Study of peristalsis showed only pattern of ineffective motility,
without any case of other speciﬁc motor disorder. In particular,
group 1 did not presented any difference in incidence of weak
peristalsis compared to HV group (78.9% vs 82%, respectively); at
the same time group 2 and 3 showed a signiﬁcantly (p < 0.001)
increase in weak peristalsis (69% and 40%, respectively. Bolus
transit patterns reﬂected the impairment of motility, being signif-
icantly incomplete in group 2 and 3 (the latter with worsened
pattern) than HV and group 1 (Table 1).3.3. 24 h MII-pH
At the 24 h MII-pH monitoring, group 1 showed an increase in
acid exposure time (in both position) compared to HV; however
none of the subjects was found to have a pathological acid exposure
and the difference between the two groups were not signiﬁcant. At
the same way, patterns of reﬂux (number of acid and weakly acid)
did not differ.
Groups 2 and 3 showed a signiﬁcant increase in esophageal acid
exposure time (in both position), being pathological in all subjects.
In particular group 3 showed a signiﬁcant increase also when
compared to group 2, especially for acid exposure in recumbent
position (p < 0.001). Regarding pattern of reﬂux, group 3 was found
to have the greatest incidence of reﬂux episodes (both acid and
weakly acid) than HV and groups 1 and 2. All data are summarized
in Table 2.
Interestingly, there was no difference in all the variables
showing GERD according to the BMI (OR, 1.2; 95 CI, 0.8e1.7).4. Discussion
Obesity has become a signiﬁcant health problem worldwide.
While obesity is a risk factor for many diseases, it has also been
advocated as an important risk factor for the development of GERD
[30,31]. In fact, physiological studies have shown that central
obesity increases intra-gastric pressure and gastro-oesophageal
pressure gradient and is associated with anatomical disruption of
the esophagogastric junction. Thus, obesity can promote reﬂux via
these mechanical effects [32].
In obese individuals, the prevalence of GERD is supposed to be
considerably higher than in the non-obese population [12,16]. In
the population-based study at the Houston VA Medical Center, 39%
of the subjects categorized as obese [body mass index
(BMI) > 30 kg m2] had heartburn and/or regurgitation [16]. In our
population study, rate of GERD related symptoms was even higher,
with 102/124 (82%) patients complaining for heartburn and/or
regurgitation at least one time in a week.
A variety of mechanisms have been described that likely
contribute to the association of GERD and obesity. These mecha-
nisms include diminished LES pressure, increased frequency of
transient LES relaxations (TLESRs), and presence of hiatal hernia.1 (n ¼ 22) Group 2 (n ¼ 37) Group 3 (n ¼ 65)
5.3e38.4) 11.0 (5.5e12.8) 9.0 (5.9e13.2)
40 60
e90) 48 (43e82) 40 (25e65)
22 57
Table 2
Patterns of reﬂux at MII-pH. (*P < 0.05 vs HV).
HV (n ¼ 15) Group 1
(n ¼ 22)
Group 2
(n ¼ 37)
Group 3
(n ¼ 65)
% Time oesophageal pH < 4
Total
Upright
Recumbent
2.0 (0.4e3.4)
2.1 (0.5e3.2)
0.2 (0e0.3)
3.1 (1.4e4.0)
3.2 (1.5e4.0)
0.4 (0e0.7)
6.0 (3.2e8.6)*
7.4 (3.9e8.5)*
2.2 (0.7e4.8)*
10.0 (3.1e22.6)*
8.4 (1.9e22.4)*
7.2 (0.7e10.8)*
Number of reﬂuxes
Acid reﬂux pattern
Total
Upright
Recumbent
20 (10e32)
18 (9e32)
2 (0e4)
27 (13e32)
22 (13e32)
3 (0e5)
43 (31e68)*
35 (24e64)*
10 (4e14)*
63 (33.5e89)*
51 (30e81)*
10.5 (5e15.5)*
Weakly Acid reﬂux pattern
Total
Upright
Recumbent
6 (1e10)
5 (1e9)
1 (0e4)
16 (8e22)
14 (6e17)
3 (2e7)
24 (15e35)*
19 (12e34)*
5 (2e9)*
34 (20.5e45)*
30 (14e44)*
5 (2e9)*
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endoscopic signs suggestive for GERD (group 3) had the lower
mean value of LES pressure, the higher GEPG and consequently the
higher mean value of ineffective peristalsis and incomplete bolus
transit.
A hypotensive LES (<10 mmHg) isa clear risk factor for the
development of GERD and the correlation between obesity and LES
pressure has been extensively investigated.
A recent study focusing reported a total of 345 morbidly obese
patients investigated, of which 59 (18%) had a hypotensive LES
pressure. Patients with a low LES pressure were more likely to have
reﬂux symptoms than those with normal sphincters (52.6% vs.
32.1%; P ¼ 0.003) [33]. Fisher et al. investigated 30 morbidly obese
patients under evaluation for bariatric surgery. Patients with
normal results were compared with those with abnormal results
based on oesophageal manometry and 24 h pH monitoring [12].
Interestingly, no relationship between LES pressure and BMI was
observed; however, a signiﬁcant correlation between decreased
LES pressure and increased acid exposurewas observed, along with
a correlation between rising BMI and increased acid exposure and
reﬂux episodes.
In our ﬁndings, the parameters of acid reﬂux, i.e., esophageal
acid exposure, were signiﬁcantly abnormal in groups 2 and 3 vs.
HV. Acid reﬂux episodes were higher in groups 2 and 3 than in
controls. In group 1 instead, the acid reﬂuxes were similar than HV,
and lower than groups 2 and 3.
The weakly acidic episodes patterns reﬂected those acid ones
among the groups.
Schneider et al., using MII-pH, reported [34] that the number of
reﬂux episodes was signiﬁcantly higher in all obese patients than in
controls. A 2007 study investigated the association between TLESRs
and obesity by comparing three groups of subjects, all of whom did
not have GERD [13]. A total of 28 obese, 28 overweight and28
normal subjects completed questionnaires, BMI measurements,
upper endoscopy, manometry and pH recordings for both fasting
and post-prandial periods. Several signiﬁcant ﬁndings occurred
during post-prandial periods. First, overweight and obese in-
dividuals had a signiﬁcantly higher rate of TLESRs during the 2-h
period after meal ingestion. Second, the proportion of TLESRs
accompanied by acid reﬂux, and the total acid exposure were
signiﬁcantly higher in obese and overweight subjects. Finally, a
direct correlation between rising BMI, increased number of TLESRs
and an increased number of TLESRs associated with acid reﬂux was
identiﬁed [13].
In our study, instead, we showed that a subgroup of obese pa-
tients could have similar reﬂux pattern than HV. This could be
explained by the presence of a still persistent integrity of EGJ in
these patients. At HRM, in fact, group 1 showed to have a normalLES pressure, low or absent incidence of hiatal hernia, and normal
peristalsis, contributing to a valid anti reﬂux mechanism. Even if
TLESrs weren’t evaluated in this study, the total number of reﬂux
detected at MII-pH can reﬂect the presence of TLESrs.
As other contributions have pointed out [35e37] the prevalence
of pathological GER ﬁndings in obese patients with low, almost
absent, symptoms must be borne in mind in the clinical evaluation
and follow-up of such patients.
Moreover, it is still controversial whether bariatric treatment
may inﬂuence the progression of GERD, in fact, if in most cases
bariatric surgery can diminish reﬂux by losing a large amount of fat,
on the other hand some restrictive procedure can worsen or cause
the presence of GERD.
Even if previous studies excluded the possibility that surgical
restrictive interventions could induce 24 h pH-metry and/or distal
esophagus alterations [38,39], a few contributions reported that the
temporary placement of an intragastric balloon could worsen GERD
in obese patients, because it might facilitate esophageal reﬂux
through gastric distention [40]. Also, it’s still matter of debate if
sleeve gastrectomy can be performed in patients with gastro-
esophageal reﬂux. This intervention could develop GERD by
differentmechanism, as impairing anatomical component of EGJ, or
rapidly ﬁlling the narrow gastric lumen [41].
Thus, it is still unclear if patients candidate to bariatric surgery
have to perform pre-operative reﬂux testing or not.
On the basis of our results, we suggest that obese subjects with
pre-operative presence of GERD symptoms and endoscopical signs
could be tested with HRM and MII-pH before undergoing bariatric
surgery, especially for restrictive procedures. On the other hand,
obese patients without any sign of GERD could not be tested for
reﬂux, showing similar patterns to HV.
5. Conclusion
In conclusion, obese patients candidate to surgery often are
complicated by GERD. However, in order to avoid useless, expen-
sive and uncomfortable tests, esophageal reﬂux testing could be
reserved only in obese subjects with a loss of the EGJ integrity, a
condition favoring GERD.
Our proposals could be conﬁrmed only by further studies with a
larger number of cases.
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